RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Application of a Cyclooxygenase Inhibitor and Itraconazole for Pulmonary Squamous Cell Carcinoma in a Dog

      한글로보기

      https://www.riss.kr/link?id=A106158769

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      A dog with anorexia, cough, and regurgitation was referred to clinic. Diagnostic imaging revealed a solitary mass involving the right cranial and middle lung lobes, compression of the cranial vena cava, and deviation of the heart and mediastinum toward the left side because the mass. The mass was diagnosed as a squamous cell carcinoma via fine needle aspiration. Ten days later, the tumor was larger and the clinical signs were more severe. A combination of piroxicam and itraconazole was administered to control the mass. Two weeks after initiating this treatment, the tumor size decreased and the clinical signs improved significantly.
      번역하기

      A dog with anorexia, cough, and regurgitation was referred to clinic. Diagnostic imaging revealed a solitary mass involving the right cranial and middle lung lobes, compression of the cranial vena cava, and deviation of the heart and mediastinum towar...

      A dog with anorexia, cough, and regurgitation was referred to clinic. Diagnostic imaging revealed a solitary mass involving the right cranial and middle lung lobes, compression of the cranial vena cava, and deviation of the heart and mediastinum toward the left side because the mass. The mass was diagnosed as a squamous cell carcinoma via fine needle aspiration. Ten days later, the tumor was larger and the clinical signs were more severe. A combination of piroxicam and itraconazole was administered to control the mass. Two weeks after initiating this treatment, the tumor size decreased and the clinical signs improved significantly.

      더보기

      참고문헌 (Reference)

      1 Hahn F, "Primary lung neoplasia in a beagle colony" 33 : 633-638, 1996

      2 Knapp DW, "Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors" 29 : 214-218, 1992

      3 Rudin CM, "Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer" 8 : 619-623, 2013

      4 Horsman MR, "Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies" 66 : 11520-11539, 2006

      5 Kim DJ, "Openlabel, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma" 32 : 745-751, 2014

      6 Thun MJ, "Nonsteroidal antiinflammatory drugs as anticancer agents : mechanistic, pharmacologic, and clinical issues" 94 : 252-266, 2002

      7 Aftab BT, "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer" 71 : 6764-6772, 2011

      8 Devesa SS, "International lung cancer trends by histologic type : male : female differences diminishing and adenocarcinoma rates rising" 117 : 294-299, 2005

      9 Boria PA, "Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs" 224 : 388-394, 2004

      10 Mohammed SI, "Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer" 62 : 356-358, 2002

      1 Hahn F, "Primary lung neoplasia in a beagle colony" 33 : 633-638, 1996

      2 Knapp DW, "Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors" 29 : 214-218, 1992

      3 Rudin CM, "Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer" 8 : 619-623, 2013

      4 Horsman MR, "Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies" 66 : 11520-11539, 2006

      5 Kim DJ, "Openlabel, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma" 32 : 745-751, 2014

      6 Thun MJ, "Nonsteroidal antiinflammatory drugs as anticancer agents : mechanistic, pharmacologic, and clinical issues" 94 : 252-266, 2002

      7 Aftab BT, "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer" 71 : 6764-6772, 2011

      8 Devesa SS, "International lung cancer trends by histologic type : male : female differences diminishing and adenocarcinoma rates rising" 117 : 294-299, 2005

      9 Boria PA, "Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs" 224 : 388-394, 2004

      10 Mohammed SI, "Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer" 62 : 356-358, 2002

      11 Hida T, "Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines" 6 : 2006-2011, 2000

      12 Ogilvie G, "Classification of primary lung tumors in dogs : 210 cases(1975-1985)" 195 : 106-108, 1989

      13 Moulton J, "Classification of lung carcinomas in the dog and cat" 18 : 513-528, 1981

      14 Sandler AB, "COX-2 inhibition and lung cancer" 31 : 45-52, 2004

      15 Andersen S, "Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy" 4 : 463-471, 2009

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2004-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2002-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.05 0.05 0.04
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.04 0.04 0.213 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼